Bakhtiyarova K.Z., Boyko A.N., Vlasov Y.V., Goncharova Z.A., Davydovskaya M.V., Zakharova M.N., Malkova N.A., Nilov A.I., Sivertseva S.A., Spirin N.N., Totolyan N.A., Khabirov F.A., Shumilina M.V. Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(3):93-99. (In Russ.) https://doi.org/10.14412/2074-2711-2020-3-93-99
Editor-in-Chief
Parfenov V.A.
Email this article (Login required)
Email the author (Login required) 
